You are here: Home » News » COMPANY NEWS » 2017 pharmaceutical industry trend forecast: three areas, thirteen Aspect

2017 pharmaceutical industry trend forecast: three areas, thirteen Aspect

Views: 11     Author: sinojoinsun     Publish Time: 2017-02-09      Origin:

In 2016, the Chinese-funded overseas mergers and acquisitions record highs, such as CITIC Industrial Fund $ 1.05 billion acquisition of Singapore's fourth largest heart stent manufacturer Baisheng International; Fosun Pharma 12.6 billion acquisition of Indian pharmaceutical company Gland; Renfu medicine 550 million US dollars The acquisition of the United States Epic Pharma; Green Leaf Pharmaceutical 245 million euros acquisition of the European Acino AG; three Connaught biological acquisition Trividia and PTS cost more than 1.5 billion; Shanghai Pharmaceutical acquisition of Australia Vitaco cost 900 million

>>Pharmaceutical industry
1. Overseas mergers and acquisitions accelerate
2. R & D efforts to improve
3. Modernization of Chinese medicine by the attention
4. Sales outsourcing
5. Self-built or co-organized electricity supplier
6. To the downstream industry extension
7. Unprecedented increase in industry concentration
8.Electronics business platform to be sought after
9. Sales category diversification
10.DTP pharmacy into the scale
11. Drugstore + clinic
12. into the era of chronic disease management
13. Service upgrade



Tel: +86 (0)27 87207098
Fax: +86 
(0)27 87207098-804
Office add.: F19, Bldg. 9 Guanggu Headquarters International, No. 62 Guanggu Ave., Wuhan, Hubei Prov., 430073, China.
Factory add.: No.988 Chibi Ave. Chibi City, Hubei Prov., China.


Copyright  2016 Wuhan Sino Joinsun Technology & Trade Co., Ltd All rights reserved.  Supported by Leadong